Roy, V., LaPlant, B. R., Gross, G. G., Bane, C. L., & Palmieri, F. M. (2009). Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531). Oxford University Press.
Citação norma ChicagoRoy, V., B. R. LaPlant, G. G. Gross, C. L. Bane, and F. M. Palmieri. Phase II Trial of Weekly Nab (nanoparticle Albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in Combination With Gemcitabine in Patients With Metastatic Breast Cancer (N0531). Oxford University Press, 2009.
MLA citiranjeRoy, V., et al. Phase II Trial of Weekly Nab (nanoparticle Albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in Combination With Gemcitabine in Patients With Metastatic Breast Cancer (N0531). Oxford University Press, 2009.